GA&FNB | SP&EPI | GA&LIA | SP&LIA | |
---|---|---|---|---|
Patients | n = 82 | n = 51 | n = 86 | n = 61 |
Gender | f = 48; m = 34 | f = 31; m = 20 | f = 52; m = 34 | f = 38; m = 23 |
Age | 67 ± 11.4 | 71 ± 9.3 | 68 ± 10.2 | 70 ± 9.0 |
Chronic pain patient | n = 5(6.1%) with opioid: n = 2 | n = 2 (3.9%) with opioid: n = 1 | n = 5(5.8%) with opioid: n = 3 | n = 2 (3.3%) with opioid: n = 1 |
Piritramide | OP: n = 34 (41.4%): 10.0 mg ± 5.4 | OP: n = 6 (11.8%): 6.9 mg ± 1.9 | OP: n = 53 (61.6%): 9.9 mg ± 4.4 | OP: n = 6 (10.0%): 7.5 mg ± 0.0 |
Day 1: n = 7 (8.5%): 8.6 mg ± 2.8 | Day 1: n = 1 (2.0%): 7.5 mg ± 0.0 | Day 1: n = 6 (7.0%): 9.0 mg ± 3.7 | Day 1: n = 6 (10.0%): 8.8 mg ± 3.1 | |
Day 2: n = 2 (2.4%): 7.5 mg ± 0.0 | Day 2: n = 1 (2.0%): 7.5 mg ± 0.0 | Day 2: n = 1 (1.2%): 9.0 mg ± 3.7 | Day 2: n = 2 (3.3%): 10.8 mg ± 4.6 | |
Salvage pain management | n = 4 (4.9%) →PCIA: n = 4 | n = 7 (13.7%) →PCIA: n = 1 →3in1: n = 6 | n = 9 (10.5%) →3in1: n = 9 | n = 9 (14.8%) →3in1: n = 8 →PCIA: n = 4 |
LIA | – | – | 160 ml | 160 ml |
Dexamethasone | – | – | 16.4 mg ± 3.1 | 15.7 mg ± 3.1 |